Letter to Editor: Screening Colonoscopy in Patients Evaluated for Liver Transplantation: Look Before You Leap
Chimezie U. Mbachi, Ayokunle T. Abegunde – 23 May 2019
Chimezie U. Mbachi, Ayokunle T. Abegunde – 23 May 2019
Matías E. Carnevale, Natalia Lausada, Leonardo Juan de Paz, Pablo Stringa, Mariana Machuca, Martin Rumbo, Edgardo E. Guibert, Claudio Tiribelli, Gabriel E. Gondolesi, Joaquin V. Rodriguez – 23 May 2019 – Organ transplantation is the treatment of choice against terminal and irreversible organ failure. Optimal preservation of the graft is crucial to counteract cold ischemia effects.
Benedikt Schaefer, Armin Finkenstedt, Maria Effenberger, André Viveiros, Herbert Tilg, Heinz Zoller – 23 May 2019
Julie K. Heimbach, Timucin Taner – 23 May 2019
Lovkesh Anand, Ashok Choudhary, Shiv K. Sarin – 23 May 2019
Daniel J. Firl, Kazunari Sasaki, John McVey, Vera Hupertz, Kadakkal Radhakrishnan, Masato Fujiki, Bijan Eghtesad, Charles M. Miller, Cristiano Quintini, Koji Hashimoto – 22 May 2019 – This study estimated the utility of technical variant grafts (TVGs), such as split/reduced liver transplantation (SRLT) and living donor liver transplantation (LDLT), in pediatric acute liver failure (PALF). PALF is a devastating condition portending a poor prognosis without liver transplantation (LT).
Alisa Likhitsup, Ammar Hassan, Jessica Mellinger, Frederick Askari, Gerald S. Winder, Naba Saeed, Christopher J. Sonnenday, Pratima Sharma, Robert J. Fontana – 22 May 2019 – Tobacco use has been associated with poorer outcomes after liver transplantation (LT). Our study examined the effect on LT listing outcomes of a newly implemented policy prohibiting the use of all tobacco products compared with a prior restrictive policy.
Molly K. Groose, Breanna N. Aldred, Joshua D. Mezrich, Laura L. Hammel – 22 May 2019 – Intracardiac thrombus (ICT) is an intraoperative complication with high mortality that occurs during orthotopic liver transplantation (OLT). Patients with end‐stage liver disease have compromised coagulation pathways, and when combined with stressors of surgery, thrombi can form. However, it is unknown which patients are most likely to develop ICT. We performed a retrospective cohort study of all OLT patients at our hospital from 2010 to 2017 to identify risk factors for ICT.
Injection Drug Use (IDU) remains the leading risk factor for HCV. Unfortunately, significant obstacles limit every aspect of the HCV care cascade in this population.
21 May 2019